Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

NCT06004115 is registered in ClinicalTrials.gov with Laureate Institute for Brain Research, Inc. as lead sponsor.

NCT NCT06004115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06004115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Lead sponsor
Laureate Institute for Brain Research, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
November 8, 2023
Completion date
December 31, 2027
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety and fear, anxiety disorders, anxious depression, depression, depression, anxiety, fear